基本信息
浏览量:190
职业迁徙
个人简介
Andrew H. Limper, M.D., studies lung defense and elimination of fungal infections, such as pneumocystis pneumonia, in patients with impaired defense systems. Lung infections (pneumonias) are particularly life-threatening in people with weakened host immunity. Dr. Limper and his team seek to find new ways beyond traditional antibiotics to prevent and fight lung infections in these individuals.
Additional research interests focus on interstitial lung diseases and pulmonary fibrosis. Dr. Limper's laboratory studies the causes and mechanisms of pulmonary fibrosis in an effort to identify new drug combinations that may be beneficial for patients with these disorders.
研究兴趣
论文共 408 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
The Cell Surface (2024): 100123
ANTIMICROBIAL AGENTS AND CHEMOTHERAPYno. 2 (2024)
A.H. Limper, S. Rajagopalan, B.J. Bartholmai, Q.T. Do, C.C. Nwakama, M.B. Herberts, J.J. McCoy, D.R. Holmes, III, T. Peikert
C23. MACHINE LEARNED: AI-DRIVEN SOLUTIONS IN ILD AND LUNG TRANSPLANT (2024)
Antimicrobial agents and chemotherapyno. 2 (2024): e0081123-e0081123
C98. ENERGIZING THE LUNG: MITOCHONDRIA AND METABOLIC PATHWAYS (2024)
Min Hyung Ryu,Jeong H. Yun, Kangjin Kim,Michele Gentili,Auyon Ghosh,Frank Sciurba,Lucas Barwick,Andrew Limper,Gerard Criner,Kevin K. Brown, Robert Wise,Fernando J. Martinez,
crossref(2024)
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2024)
Chestno. 1 (2023): 146-149
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn